See analyst estimates and all valuation multiples for BioTech
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $925B | 14.8x | 33.0x | |
| $509B | 5.4x | 14.3x | |
| $457B | 7.5x | 17.8x | |
| $277B | 5.0x | 12.1x | |
| $264B | 4.1x | 9.1x | |
| $244B | 5.5x | 21.9x | |
| $214B | 5.9x | 12.0x | |
| $190B | 3.0x | 7.7x | |
| $174B | 7.1x | 22.8x | |
| $168B | 5.8x | 10.7x | |
| $140B | 2.9x | 7.8x | |
| $117B | 2.7x | 8.0x | |
| $106B | 8.9x | 20.7x | |
| $81.0B | 10.1x | 20.0x | |
| $77.8B | 1.5x | 7.0x | |
| $71.0B | 2.9x | 10.0x | |
| $70.8B | 2.4x | 9.1x | |
| $67.9B | 4.2x | 12.6x | |
| $67.1B | 4.7x | 13.3x | |
| $57.3B | 6.1x | 13.9x | |
| $55.9B | 6.7x | 21.8x | |
| $53.7B | 11.5x | 38.5x | |
| $53.4B | 14.6x | 80.0x | |
| $32.5B | 14.9x | -101.7x | |
| $28.2B | 13.7x | 35.3x | |
| $26.5B | 7.7x | 25.3x | |
| $26.4B | 1.9x | 6.4x | |
| $26.2B | 2.4x | 12.0x | |
| $26.2B | 2.0x | 8.7x | |
| $23.7B | 7.9x | 8.3x | |
| $21.1B | 7.9x | 33.2x | |
| $20.8B | 60.1x | 38.8x | |
| $17.8B | 9.5x | 69.3x | |
| $12.0B | 13.6x | -32.2x | |
| $11.1B | 2.5x | 6.7x | |
| $10.6B | 1.6x | 8.7x | |
| $10.4B | 4.5x | 11.2x | |
| $10.3B | 5.0x | 13.6x | |
| $10.3B | 3.1x | 7.5x | |
| $10.1B | 1.6x | 12.8x | |
| $9.5B | 3.0x | 12.3x | |
| $9.4B | 7.7x | 21.9x | |
| $8.9B | 496.8x | -13.5x | |
| $8.1B | n/a | n/a | |
| $7.3B | 11.9x | -43.8x | |
| $7.2B | n/a | -17.9x | |
| $7.0B | 14.8x | 49.3x | |
| $6.9B | 93.2x | -3817.5x | |
| $6.5B | 88735.1x | n/a | |
| $6.2B | 2.1x | 9.1x | |
| $6.2B | 2.0x | 8.2x | |
| $6.1B | 15.9x | 37.2x | |
| $5.8B | 110.0x | -18.7x | |
| $5.8B | n/a | n/a | |
| $5.7B | n/a | -21.4x | |
| $5.0B | 1.8x | 4.9x | |
| $5.0B | 57.9x | -40.5x | |
| $5.0B | 8.4x | 37.3x | |
| $5.0B | 5.9x | 29.1x | |
| $4.9B | 5.8x | 20.3x | |
| $4.9B | 8.4x | 25.7x | |
| $4.7B | 9.3x | 24.3x | |
| $4.7B | 1.3x | 8.2x | |
| $4.7B | 3.8x | 15.4x | |
| $4.6B | 2.7x | 5.2x | |
| $4.6B | 3.3x | 9.8x | |
| $4.5B | 4.8x | 13.9x | |
| $4.3B | n/a | -11.0x | |
| $4.3B | 2.8x | 7.7x | |
| $4.2B | 4.2x | -32.2x | |
| $4.2B | 5.9x | n/a | |
| $4.2B | n/a | n/a | |
| $3.9B | 3.1x | 18.4x | |
| $3.8B | 3.7x | 17.1x | |
| $3.7B | 397.8x | -6.3x | |
| $3.6B | 2.1x | 10.6x | |
| $3.6B | 3.9x | 16.0x | |
| $3.4B | 13.5x | 34.2x | |
| $3.4B | 4.3x | 77.5x | |
| $3.3B | 4.9x | 15.3x | |
| $3.3B | n/a | -6.5x | |
| $3.1B | n/a | n/a | |
| $3.1B | 56.6x | -12.0x | |
| $3.0B | 3.4x | 13.8x | |
| $2.8B | 4.1x | 17.3x | |
| $2.6B | 4.0x | 13.5x | |
| $2.4B | 5.7x | -81.2x | |
| $2.4B | 40.4x | -58.4x | |
| $2.4B | 3.4x | 18.2x | |
| $2.3B | 1.6x | 10.9x | |
| $2.3B | 2.9x | 18.5x | |
| $2.1B | 5.6x | 16.2x | |
| $2.1B | 1.6x | 8.7x | |
| $2.1B | 1.9x | 9.5x | |
| $2.1B | 9.1x | 34.9x | |
| $2.0B | 0.8x | 5.7x | |
| $1.9B | 2.4x | 9.0x | |
| $1.8B | 4.7x | 12.4x | |
| $1.8B | 1.7x | 12.0x | |
| $1.6B | 3.8x | 12.0x |